Pozdeutinurad
N/A
Report date: 2026/05/26 20:00:28
NME
Base Information
Drug NamePozdeutinurad
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesArthrosi Therapeutics Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesGuangzhou Ruianbo Pharmaceutical Technology Co LtdArthrosi Therapeutics IncBioDuro Llc +[5]
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A